A. Nomoto

Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine.

S. Mutoh, A. Nomoto, H. Hagihara, 1988, Atherosclerosis.

Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition--a pathogenic factor in atherosclerosis.

S. Mutoh, A. Nomoto, I. Yamaguchi, 1988, Atherosclerosis.

Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery.

T. Ono, S. Mutoh, T. Ono, 1991, Atherosclerosis.

Inflammatory responses in cuff-induced atherosclerosis in rabbits.

S. Mutoh, Y. Ohkubo, A. Nomoto, 1987, Atherosclerosis.

Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.

Y. Notsu, H. Nirei, M. Shoubo, 1993, The Journal of pharmacology and experimental therapeutics.

Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.

S. Mutoh, A. Nomoto, I. Yamaguchi, 1987, Atherosclerosis.